Alkem Laboratories Ltd

Since its inception in 1973, Alkem has steadily grown to become India’s 7th largest pharmaceutical company with sales revenues exceeding USD 500 million

Alkem, a leading generic and specialty drug manufacturer, is India’s seventh largest pharmaceutical company with sales revenues exceeding USD 500 million, with a CAGR of 16% over the last 5 years.

Alkem is a pioneer in the acute and chronic therapeutic segments with extensive brand share in the Central Nervous System, Gastro-intestinal, Anti-diabetic, Anti-malarial, Cardiovascular, Immunosuppressants, and Neutraceuticals segments. Alkem’s success is highlighted by its leadership in the Anti-infective and Pain Management segments. Of its portfolio of 800 brands, 3 brands, Taxim (Cefotaxim), Clavam (Amoxicillin + Clavulanic Acid), and Sumo (Paracetamol) are ranked among the top 25 brands in India, while 14 feature among the top 300 brands in the Indian market.

Alkem’s state-of-the-art manufacturing facilities across 7 locations in India, approved by global regulatory authorities including the US FDA, UK MHRA, MCC South Africa, evidences Alkem’s capabilities in offering quality generic and branded products in over 48 countries across the globe.

---

---